Silent myocardial ischemia in asymptomatic patients with type 2 diabetes mellitus without previous histories of cardiovascular disease

被引:7
|
作者
Kawano, Yuki [1 ]
Takemoto, Masao [1 ]
Mito, Takahiro [1 ]
Morisaki, Hiroko [2 ]
Tanaka, Atsushi [1 ]
Sakaki, Yuka [2 ]
Matsuo, Atsutoshi [1 ]
Abe, Kentaro [2 ]
Hida, Satoru [1 ]
Mukae, Kumiko [2 ]
Okazaki, Teiji [1 ]
Tayama, Kei-ichiro [1 ]
Inoguchi, Toyoshi [3 ]
Yoshitake, Kiyonobu [1 ]
Kosuga, Ken-ichi [1 ]
机构
[1] Munakata Suikokai Gen Hosp, Ctr Cardiovasc, 5-7-1 Himakino, Fukutsu 8113298, Japan
[2] Munakata Suikokai Gen Hosp, Diabet & Endocrine Ctr, Fukutsu 8113298, Japan
[3] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan
关键词
Diabetes mellitus; Asymptomatic; Silent myocardial ischemia; Disease duration; Family history; CORONARY-ARTERY-DISEASE; LOW-DOSE ASPIRIN; PRIMARY PREVENTION; MULTIFACTORIAL INTERVENTION; GLYCEMIC CONTROL; GLUCOSE CONTROL; FOLLOW-UP; MORTALITY; OUTCOMES; THERAPY;
D O I
10.1016/j.ijcard.2016.04.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The number of patients with type 2 diabetes mellitus (T2DM) continues to increase all over the world. Cardiovascular disease (CVD), especially coronary artery disease (CAD), is a major cause of the morbidity and mortality in patients with T2DM. The prognosis of patients with silent myocardial ischemia (SMI) is worse than that in those without. Methods and results: Thus, to assess how many patients with SMI existed among those patients, CVD screening tests were performed in 128 asymptomatic patients with T2DM without previous histories of CVD. SMI could be detected in 24 patients (19%) by exercise stress tests and/or the coronary fractional flow reserve. Their 12-lead electrocardiogram and cardiac ultrasonography were both normal. Compared to those without SMI, those with had a statistically significant longer history of T2DM (17 +/- 1 versus 11 +/- 1 years, p = 0.006), and the co-existence of a family history of CVD (42% versus 21%, p = 0.037). Furthermore, these factors were demonstrated as independent risk factors of SMI by a multivariate analysis (Odds ratio 1.060 and 4.000, respectively), and in accordance with the disease duration of T2DM, the prevalence of patients with SMI has been increasing (p = 0.019). Conclusions: Physicians should be aware of these conditions when examining patients with T2DM, especially with a family history of CVD and/or long disease duration (>11 years) of T2DM, even though they have no symptoms, previous histories of CVDs, and/or abnormal findings on the 12-lead electrocardiogram and cardiac ultrasonography. This may be an effective, safe, and attractive diagnostic strategy for those asymptomatic patients with T2DM. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:151 / 155
页数:5
相关论文
共 50 条
  • [31] Risk of silent myocardial ischemia detected by single photon emission computed tomography (SPECT) among asymptomatic Chinese patients with type 2 diabetes
    Zhu Xiao-Rong
    Zhang Hui-Rong
    Li Mei
    Zhou Zhen
    Liu Wei
    Lu Jing
    Yang Guang-Ran
    Zhou Jian-Bo
    Yang Jin-Kui
    MEDICINE, 2019, 98 (20)
  • [32] Inflammatory cardiovascular risk markers and silent myocardial ischemia in type 2 diabetic patients
    Malesevic, Gabrijela
    Popovic-Pejicic, Snjezana
    Markovic, Aleksandra
    Soldat-Stankovic, Valentina
    VOJNOSANITETSKI PREGLED, 2022, 79 (06) : 584 - 590
  • [33] Screening for silent myocardial ischaemia in patients with type 2 diabetes mellitus: a quest to improve selection of the target screening population
    De Keyzer, Eva
    Kerkhove, Dirk
    Van Camp, Guy
    De Sutter, Johan
    Achtergael, Wim
    Keymeulen, Bart
    Weytjens, Caroline
    ACTA CARDIOLOGICA, 2011, 66 (06) : 715 - 720
  • [34] Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen
    Chillaron, Juan J.
    Flores-Le Roux, Juana A.
    Benaiges, David
    Pedro-Botet, Juan
    WORLD JOURNAL OF CLINICAL CASES, 2014, 2 (09) : 415 - 421
  • [35] Concerning the Debate on Screening Patients with Diabetes Mellitus (DM) for Silent Myocardial Ischemia
    Aaty, Ahmed Abdel
    JOURNAL OF NUCLEAR CARDIOLOGY, 2016, 23 (05) : 1186 - 1186
  • [36] Type 2 diabetes mellitus and myocardial ischemic preconditioning in symptomatic coronary artery disease patients
    Rezende, Paulo Cury
    Rahmi, Rosa Maria
    Uchida, Augusto Hiroshi
    Alves da Costa, Leandro Menezes
    Scudeler, Thiago Luis
    Garzillo, Cibele Larrosa
    Lima, Eduardo Gomes
    Wainrober Segre, Carlos Alexandre
    Girardi, Priscyla
    Takiuti, Myrthes
    Silva, Marcela Francisca
    Hueb, Whady
    Franchini Ramires, Jose Antonio
    Filho, Roberto Kalil
    CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [37] Baroreflex Sensitivity Predicts Cardiovascular Events in Patients With Type 2 Diabetes Mellitus Without Structural Heart Disease
    Okada, Norihiro
    Takahashi, Naohiko
    Yufu, Kunio
    Murozono, Yukichi
    Wakisaka, Osamu
    Shinohara, Tetsuji
    Anan, Futoshi
    Nakagawa, Mikiko
    Hara, Masahide
    Saikawa, Tetsunori
    Yoshimatsu, Hironobu
    CIRCULATION JOURNAL, 2010, 74 (07) : 1379 - 1383
  • [38] Oncostatin M is a novel biomarker for coronary artery disease - A possibility as a screening tool of silent myocardial ischemia for diabetes mellitus
    Ikeda, Shohei
    Sato, Koichi
    Takeda, Morihiko
    Miki, Keita
    Aizawa, Kentaro
    Takada, Tsuyoshi
    Fukuda, Koji
    Shiba, Nobuyuki
    IJC HEART & VASCULATURE, 2021, 35
  • [39] Cardiovascular Disease in Japanese Patients with Type 2 Diabetes Mellitus
    Fujihara, Kazuya
    Sone, Hirohito
    ANNALS OF VASCULAR DISEASES, 2018, 11 (01) : 2 - 14
  • [40] Chronic Kidney Disease is the Key Factor of Potential Myocardial Ischemia and Worse Prognosis in Asymptomatic Patients With Diabetes Mellitus.
    Wakabayashi, Kohei
    Suzuki, Toshiaki
    Shibata, Keita
    Furuya, Takahiro
    Sato, Chisato
    Nishikura, Tenjin
    Matsui, Taiki
    Ikeda, Naoko
    Honda, Yuki
    Kikuchi, Miwa
    Miyoshi, Fumito
    Tanno, Kaoru
    Tanno, Kaoru
    CIRCULATION, 2018, 138